AFG
Albion Financial Group’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-28
| Closed | -$1K | – | 644 |
|
|
2021
Q3 | $1K | Hold |
28
| – | – | ﹤0.01% | 488 |
|
|
2021
Q2 | $1K | Buy |
+28
| New | +$1K | ﹤0.01% | 483 |
|
|
2020
Q4 | $1K | Buy |
+28
| New | +$1K | ﹤0.01% | 449 |
|
|
2017
Q1 | – | Sell |
-64,619
| Closed | -$2.49M | – | 196 |
|
|
2016
Q4 | $2.49M | Sell |
64,619
-29,675
| -31% | -$1.14M | 0.41% | 46 |
|
|
2016
Q3 | $4.07M | Buy |
94,294
+8,730
| +10% | +$377K | 0.7% | 37 |
|
|
2016
Q2 | $3.71M | Buy |
85,564
+5,898
| +7% | +$256K | 0.67% | 29 |
|
|
2016
Q1 | $3.23M | Buy |
79,666
+13,797
| +21% | +$559K | 0.55% | 33 |
|
|
2015
Q4 | $2.66M | Sell |
65,869
-30,096
| -31% | -$1.21M | 0.46% | 37 |
|
|
2015
Q3 | $3.69M | Buy |
95,965
+5,110
| +6% | +$196K | 0.67% | 25 |
|
|
2015
Q2 | $3.78M | Buy |
90,855
+2,162
| +2% | +$90K | 0.63% | 30 |
|
|
2015
Q1 | $4.09M | Buy |
88,693
+15,662
| +21% | +$723K | 0.7% | 28 |
|
|
2014
Q4 | $3.12M | Sell |
73,031
-4,099
| -5% | -$175K | 0.54% | 32 |
|
|
2014
Q3 | $3.55M | Buy |
77,130
+4,175
| +6% | +$192K | 0.63% | 30 |
|
|
2014
Q2 | $3.9M | Sell |
72,955
-109,337
| -60% | -$5.85M | 0.68% | 33 |
|
|
2014
Q1 | $9.74M | Buy |
182,292
+4,666
| +3% | +$249K | 1.8% | 15 |
|
|
2013
Q4 | $9.48M | Buy |
177,626
+928
| +0.5% | +$49.5K | 1.78% | 15 |
|
|
2013
Q3 | $8.87M | Buy |
176,698
+6,664
| +4% | +$334K | 1.89% | 11 |
|
|
2013
Q2 | $8.5M | Buy |
+170,034
| New | +$8.5M | 1.89% | 16 |
|